-
Hsp90 Inhibitor Attenuates the Development of Pathophysiological Cardiac Fibrosis in Mouse Hypertrophy via Suppression of the Calcineurin-NFAT and c-Raf-Erk Pathways. Tetsuro Marunouchi, Miyuki Nakashima, Saika Ebitani, Sakiko Umezu, Kasane Karasawa, Emi Yano, Kouichi Tanonaka Journal of cardiovascular pharmacology 77(6) 822-829 2021年6月1日
-
Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice. Tetsuro Marunouchi, Chiharu Nishiumi, Saki Iinuma, Emi Yano, Kouichi Tanonaka European journal of pharmacology 898 173987-173987 2021年5月5日
-
Effects of 17-AAG on the RIP1/RIP3/MLKL pathway during the development of heart failure following myocardial infarction in rats Tetsuro Marunouchi, Takumi Ito, Sumika Onda, Lina Kyo, Kirara Takahashi, Manami Uchida, Emi Yano, Kouichi Tanonaka Journal of Pharmacological Sciences 2021年
-
Transplantation of cardiac Sca-1-positive cells rather than c-Kit-positive cells preserves mitochondrial oxygen consumption of the viable myocardium following myocardial infarction in rats. Tetsuro Marunouchi, Kyohei Sasaki, Emi Yano, Kouichi Tanonaka Journal of pharmacological sciences 140(3) 236-241 2019年7月
-
Histone Deacetylase Inhibitor SAHA Treatment Prevents the Development of Heart Failure after Myocardial Infarction via an Induction of Heat-Shock Proteins in Rats. Shiho Nagata, Tetsuro Marunouchi, Kouichi Tanonaka Biological & pharmaceutical bulletin 42(3) 453-461 2019年3月1日
